Selling science
polio and the promise of gamma globulin
| LEADER | cam a22 4 4500 | ||
|---|---|---|---|
| 001 | 390168432 | ||
| 003 | CHVBK | ||
| 005 | 20200625103101.0 | ||
| 008 | 161201s2016 xxuab b 001 0deng| | ||
| 010 | |a 2015037355 | ||
| 020 | |a 978-0-8135-7439-4 |q hbk. | ||
| 020 | |a 0-8135-7439-0 |q hbk. | ||
| 020 | |z 978-0-8135-7440-0 |q ePub | ||
| 020 | |z 978-0-8135-7441-7 |q Web PDF | ||
| 024 | 3 | 0 | |a 9780813574394 |
| 035 | |a (IDSLU)001275092 | ||
| 035 | |a (IDSBB)006651038 | ||
| 035 | |a (NEBIS)010660000 | ||
| 035 | |a (VAUD)991021130799002852 | ||
| 035 | |a (OCoLC)927618771 | ||
| 035 | |a (EXLNZ-41BCULAUSA_NETWORK)991023453137702851 | ||
| 040 | |a DLC |b ger |d SzZuIDS LU |e rda | ||
| 041 | 0 | |a eng | |
| 050 | 0 | 0 | |a RA644.P9 |b M39 2016 |
| 060 | 4 | |a WC 556 |b .M462s 2016 | |
| 060 | 0 | 0 | |a 2017 C-382 |
| 060 | 1 | 0 | |a WC 556 |
| 082 | 0 | 0 | |a 614.5/490973 |2 23 |
| 100 | 1 | |a Mawdsley |D Stephen E. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Selling science |b polio and the promise of gamma globulin |c Stephen E. Mawdsley |
| 264 | 1 | |a New Brunswick |b Rutgers University Press |c [2016] | |
| 300 | |a xiii, 210 Seiten |b Illustrationen |c 24 cm | ||
| 490 | 0 | |a Critical issues in health and medicine | |
| 500 | |a Publié aussi sous forme numérique avec l'e-ISBN 9780813574400 au format ePub. | ||
| 500 | |a Publié aussi sous forme numérique avec l'e-ISBN 9780813574417 au format Web PDF. | ||
| 504 | |a Includes bibliographical references and index | ||
| 505 | 0 | |a Forging momentum -- Building consent for a clinical trial -- Marketing and mobilization -- Selling science -- Operation marbles and lollipops -- The national experiment | |
| 520 | 2 | |a "In Selling Science : Polio and the Promise of Gamma Globulin, medical historian Stephen E. Mawdsley examines the untold story of the first effort to control polio prior to the development of the Salk vaccine. In the early 1950s, Dr. William McD. Hammon and the National Foundation for Infantile Paralysis launched a pioneering medical experiment on a previously untried scale. Conducted on over 55,000 healthy children in Texas, Utah, Iowa, and Nebraska, this landmark study attempted to assess the safety and effectiveness of a blood component, 'gamma globulin' (which is derived by a process known as 'fractionation') to prevent paralytic polio. Although the study was condemned by many prominent health professionals, harbored potential risks, and returned dubious results, it was perceived as a triumph and used to justify a national immunization program from 1953 to 1954"-- | |
| 600 | 1 | 2 | |a Hammon, William McD |q William McDowell |d 1904-1989 |
| 600 | 1 | 0 | |a Hammon, William McD |q William McDowell |d 1904-1989 |
| 610 | 2 | 2 | |a National Foundation for Infantile Paralysis |
| 610 | 2 | 0 | |a National Foundation for Infantile Paralysis |x History |
| 648 | 7 | |a Geschichte 1951-1954 |2 gnd | |
| 650 | 2 | |a Child |0 (DNLM)D002648 | |
| 650 | 2 | |a Clinical Trials as Topic |x history |0 (DNLM)D002986Q000266 | |
| 650 | 2 | |a gamma-Globulins |x therapeutic use |0 (DNLM)D005719Q000627 | |
| 650 | 2 | |a History, 20th Century |0 (DNLM)D049673 | |
| 650 | 2 | |a Organizations, Nonprofit |x history |0 (DNLM)D009939Q000266 | |
| 650 | 2 | |a Physicians |x history |0 (DNLM)D010820Q000266 | |
| 650 | 2 | |a Poliomyelitis |x prevention & control |0 (DNLM)D011051Q000517 | |
| 650 | 2 | |a Therapeutic Human Experimentation |0 (DNLM)D036302 | |
| 650 | 2 | |a Vaccines |x therapeutic use |0 (DNLM)D014612Q000627 | |
| 650 | 7 | |a Immunglobuline |0 (DE-588)4026626-6 |2 gnd | |
| 650 | 7 | |a Impfung |0 (DE-588)4026656-4 |2 gnd | |
| 650 | 7 | |a Kinderlähmung |0 (DE-588)4163840-2 |2 gnd | |
| 650 | 7 | |a Klinisches Experiment |0 (DE-588)4164223-5 |2 gnd | |
| 650 | 0 | |a Poliomyelitis |z United States |x Prevention |x History |y 20th century | |
| 650 | 0 | |a Gamma globulins |x Research |z United States |x History |y 20th century | |
| 650 | 0 | |a Children |x Diseases |z United States |x Prevention |x History |y 20th century | |
| 650 | 0 | |a Clinical trials |z United States |x History |y 20th century | |
| 650 | 0 | |a Science |x Social aspects |x History |y 20th century | |
| 650 | 0 | |a Science |x Economic aspects |x History |y 20th century | |
| 650 | 7 | |a Poliomyélite |x Prévention |z États-Unis |y 20e siècle |2 ram | |
| 650 | 7 | |a Gammaglobulines |x Thérapeutique |z États-Unis |y 20e siècle |2 ram | |
| 650 | 7 | |a Enfants |x Maladies |x Prévention |z États-Unis |y 20e siècle |2 ram | |
| 651 | 2 | |a United States |0 (DNLM)D014481 | |
| 691 | 7 | |B u |u XB 5200 |2 idslu LR | |
| 898 | |a BK020000 |b XK020000 |c XK020000 | ||
| 900 | 7 | |a Metadata rights reserved |2 vaud | |
| 909 | 7 | |a UMHIZ-201607 |2 nebis EN | |
| 912 | 7 | |a 011 |2 IDS LU | |
| 912 | 7 | |a s1me |2 rnv | |
| 912 | 7 | |a s2ht |2 rnv | |
| 949 | |B VAUD |F iuhm |b iuhm |j HMA 26062 35p |c 810820001 | ||
| 949 | |B NEBIS |F UMBC |b UMBC |c ULCAR |j WZ 70.A-143 | ||
| 949 | |B IDSLU |F LUUHL |b LUUHL |c UHFRE |j XB 5200 2016 | ||
| 949 | |B IDSBB |F B583 |b B583 |c MAG |j IMG WC 555 M462 |x NELB5831611 | ||
| 950 | |B IDSLU |P 100 |E 1- |a Mawdsley |D Stephen E. |e Verfasser |4 aut | ||
| 950 | |B IDSLU |P 490 |E 0- |a Critical issues in health and medicine | ||
| 950 | |B IDSBB |P 100 |E 1- |a Mawdsley |D Stephen E. |e Verfasser |4 aut | ||
| 950 | |B IDSBB |P 490 |E 0- |a Critical issues in health and medicine | ||
| 950 | |B NEBIS |P 100 |E 1- |a Mawdsley |D Stephen E. |e Verfasser |4 aut | ||
| 950 | |B NEBIS |P 490 |E 0- |a Critical issues in health and medicine | ||
| 950 | |B VAUD |P 100 |E 1- |a Mawdsley |D Stephen E. |4 aut | ||
| 950 | |B VAUD |P 490 |E 0- |a Critical issues in health and medicine | ||
| 956 | 4 | |B IDSLU |C ILU50 |D ILU01 |a LUZHB |u https://www.ub.unibas.ch/tox/IDSLUZ/001275092/PDF |q pdf |x VIEW |y Inhaltsverzeichnis | |
| 986 | |a SWISSBIB |b 390168432 | ||